References
CDC. Draft: estimates of the risk of endemic transmission of Hepatitis B virus and human immunodeficiency virus to patients by percutaneous route during invasive surgical and dental procedures. Presented at the Open Meeting on the Risks of Transmission of Bloodborne Pathogens to Patients during Invasive Procedures, Atlanta, Georgia, February 21–22, 1991
Feldstein PJ. Health economics, 3rd ed., John Wiley & Sons, New York, 1988
Gerberding JL. Expected costs of implementing a mandatory human immunodeficiency virus and hepatitis B virus testing and restriction program for healthcare workers performing invasive procedures. Infection Control and Hospital Epidemiology 12(7): 443–447, 1991
Joint Working Party of the Hospital Infection Society and the Surgical Infection Study Group. Risks to surgeons and patients from HIV and hepatitis: guidelines on precautions and management of exposure to blood or body fluids. British Medical Journal 305: 1337–1343, 1992
Russo G, La Croix SJ. A second look at the cost of mandatory human immunodeficiency virus and hepatitis b virus testing for healthcare workers performing invasive procedures. Infection Control and Hospital Epidemiology 13(2): 107–110, 1992
United Kingdom Department of Health. AIDS-HIV infected health care workers: occupational guidance for healthcare workers, their physicians and employers. Recommendation of the expert advisory group on AIDS. Health Publications Unit, Lancashire, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Malek, M., Davey, P. Economics of Mandatory HIV and Hepatitis B Virus Testing for Healthcare Workers Performing Surgical Procedures. PharmacoEconomics 4, 401–404 (1993). https://doi.org/10.2165/00019053-199304060-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-199304060-00002